| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/18/2005 | WO2005074967A2 Progastrin derived peptides |
| 08/18/2005 | WO2005074677A1 Transgenic animals for assessing drug metabolism and toxicity in man |
| 08/18/2005 | WO2005074650A2 Modified human four helical bundle polypeptides and their uses |
| 08/18/2005 | WO2005074647A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 08/18/2005 | WO2005074626A2 Compositions, methods and uses for a novel family of peptides |
| 08/18/2005 | WO2005074546A2 Modified human growth hormone polypeptides and their uses |
| 08/18/2005 | WO2005074524A2 Modified human interferon polypeptides and their uses |
| 08/18/2005 | WO2005074436A2 Self-assembling split-fluorescent protein systems |
| 08/18/2005 | WO2005061545A3 Nogoa antibodies for the treatment of alzheimer disease |
| 08/18/2005 | WO2005061544A3 Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
| 08/18/2005 | WO2005060996A3 Method of altering the pka type i signalling pathway |
| 08/18/2005 | WO2005058952A3 Ztnf13, a tumor necrosis factor |
| 08/18/2005 | WO2005058369A3 Compositions of l-caldesmon for treating viral infection |
| 08/18/2005 | WO2005055930A3 Recombinant factor viii having increased specific activity |
| 08/18/2005 | WO2005052159A8 Latent phase viral interleukin-10-(vii-10) and uses thereof |
| 08/18/2005 | WO2005052123A3 Polynucleotide encoding a novel human g-protein coupled receptor variant of the relaxin receptor, hgprbmy5v1, and variants thereof |
| 08/18/2005 | WO2005052122A3 METHODS FOR CONTROLLING PATHOLOGICAL ANGIOGENESIS BY INHIBITION OF α6β4 INTEGRIN |
| 08/18/2005 | WO2005047487A8 Motoneuronotrophic factor gene sequences |
| 08/18/2005 | WO2005045056A3 Radioactive multiplexing analytical methods |
| 08/18/2005 | WO2005044197A3 Synthesis of glycopeptides with superior pharmacokinetic properties |
| 08/18/2005 | WO2005042559A9 Capture and release based isotope tagged peptides and methods for using the same |
| 08/18/2005 | WO2005039632B1 Colorectal cancer antigen |
| 08/18/2005 | WO2005033133A3 Polynucleotides encoding erbb-2 polypeptides and kits and methods using same |
| 08/18/2005 | WO2005030250A3 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 08/18/2005 | WO2005029067A3 Method of diagnosing breast cancer |
| 08/18/2005 | WO2005026206A3 Vegf-induced genes and their therapeutic use |
| 08/18/2005 | WO2005023980A3 Use of complement protein c3 and its derivatives in enhancing mammalian embryo development |
| 08/18/2005 | WO2005017174A3 Process for the purification of recombinant polypeptides |
| 08/18/2005 | WO2005017125A3 Method for isolation and replication of infectious human hepatitis-c virus |
| 08/18/2005 | WO2005016233A3 Botulinum neurotoxin b receptors and use thereof |
| 08/18/2005 | WO2005014619A3 Heparin-binding peptides and uses thereof |
| 08/18/2005 | WO2005013899A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/18/2005 | WO2005010044A3 Il-17 a/f heterologous polypeptides and therapeutic uses thereof |
| 08/18/2005 | WO2005007691A3 East coast fever vaccine based on ctl-specific schizont antigens |
| 08/18/2005 | WO2005007682A3 A peptide and a pharmaceutical composition, and their medical applications |
| 08/18/2005 | WO2005007663A3 Fluorogenic enzyme substrates and uses thereof |
| 08/18/2005 | WO2005001096A8 Vaccines against sars |
| 08/18/2005 | WO2004100898A3 Therapeutic use of anti-cs1 antibodies |
| 08/18/2005 | WO2004094597A3 Anthozoan fluorescent protein genes |
| 08/18/2005 | WO2004091490A3 Somatostatin-dopamine chimeric analogs |
| 08/18/2005 | WO2004085469A3 Secreted protein family |
| 08/18/2005 | WO2004076614A3 Human nucleic acid sequences obtained from prostatic carcinomas |
| 08/18/2005 | WO2004067727A8 Mixing and matching tc proteins for pest control |
| 08/18/2005 | WO2004062366A3 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots |
| 08/18/2005 | WO2004058949A3 Wnt-1 inhibitory factor-1 (wif-1) molecules and uses thereof |
| 08/18/2005 | WO2004054516A3 Antagonists for human prolactin |
| 08/18/2005 | WO2004045519A3 Induction of apoptosis by hiv-1 infected monocytic cells |
| 08/18/2005 | WO2004020463A3 Mutant protein and refolding method |
| 08/18/2005 | WO2004011595A3 Vectors for transferring molecules of interest in target cells |
| 08/18/2005 | WO2003072601A8 Method for producing hypoallergenic major birch pollen allergens rbet v 1 |
| 08/18/2005 | WO2003004608A3 Drug metabolizing enzymes |
| 08/18/2005 | US20050183173 Fine mapping and application of dna markers linked to a gall midge resistance gene for marker-aided selection in rice |
| 08/18/2005 | US20050183169 Transcription regulatory gene and peptide |
| 08/18/2005 | US20050183167 Microspore-specific promoter and method for producing hybrid plants |
| 08/18/2005 | US20050183166 Gene controlling flowering time and method for controlling flowering time in plants using the gene |
| 08/18/2005 | US20050183165 Grapevine leafroll virus (type 2) proteins and their uses |
| 08/18/2005 | US20050183162 Recombinant crop plants containing nucleotide sequences coding pokeweed antiviral protein (PAP) and comprising enhanced disease resistance; fungicides |
| 08/18/2005 | US20050183161 AXMI-010, a delta-endotoxin gene and methods for its use |
| 08/18/2005 | US20050183148 Lymphocyte surface receptor that binds caml and methods of use thereof |
| 08/18/2005 | US20050182250 Nucleotide sequences coding fluorescent reporter protlein and scaffolds for use as diagnostic and imaging tool in genetic analysis |
| 08/18/2005 | US20050182249 Nucleotide sequences coding tumor suppressor protein for use in diagnosis, prevention and treatment of cancer; antitumor agents |
| 08/18/2005 | US20050182246 An active site containing a hydrophobic surface of a binding pocket of amino acid residues Tyr-161, Phe-157, Arg-186, Leu-182, Arg-117, Phe-134, Leu-135, Leu-154, Phe-149, Ile-142, His-146, Arg-114, Lys-190, Ser-193, Ala-158, Tyr-138, Leu-115, Met-123, Phe-165, and Pro-118; improved gas binding property |
| 08/18/2005 | US20050182245 Novel receptors |
| 08/18/2005 | US20050182244 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 08/18/2005 | US20050182243 Membrane scaffold proteins |
| 08/18/2005 | US20050182242 Microarray comprising double tagged fusion protein for monitoring and classification of polypeptide interactions in preferential species; high-throughput assay |
| 08/18/2005 | US20050182017 Immunostimulatory nucleic acid molecules |
| 08/18/2005 | US20050182014 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (GHRH) supplementation |
| 08/18/2005 | US20050182011 Use inhibitors of Transient Receptor Potential (TRP) channels to block non-voltage gated calcium flux into cells |
| 08/18/2005 | US20050181998 Prion inhibiting peptides and derivatives thereof |
| 08/18/2005 | US20050181997 For preservation of hematopoietic progenitor cells; useful for isolating rare, primitive progenitor cells; nontoxic |
| 08/18/2005 | US20050181995 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof |
| 08/18/2005 | US20050181994 Soluble, recombinant CD40L variant proteins that may be expressed solubly in E. coli |
| 08/18/2005 | US20050181993 Method for using lipoprotein associated coagulation inhibitor to treat sepsis |
| 08/18/2005 | US20050181992 Isolated from the submaxiliary saliva glands of shrews; calcium channel blocker, analgesic, insecticide |
| 08/18/2005 | US20050181991 Use of artemin, a member of the GDNF ligand family |
| 08/18/2005 | US20050181980 Administering a formulation comprising an effective amount of:a sulfonylurea receptor 1 (SUR1) antagonist that reduces the activity of a NCCa-ATP channel; a pharmaceutically acceptable carrier |
| 08/18/2005 | US20050181976 coupled to therapeutic proteins or peptides; biochemical conjugation |
| 08/18/2005 | US20050181973 comprising alternating hydrophobic and hydrophilic amino acids that are complementary and structurally compatible; three-dimensional scaffolds, encapsulating cells, used for cell cultures, tissue engineering and tissue repair |
| 08/18/2005 | US20050181972 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells |
| 08/18/2005 | US20050181506 Chromosome-based platforms |
| 08/18/2005 | US20050181500 A recombinant expression vector; an isolated nucleic acid molecule; diagnosis of high blood pressure, obesity |
| 08/18/2005 | US20050181484 Culturing porcine bone marrow stem cells in nutrient broth comprising interleukins and colony stimulating factor; propagating mast cell |
| 08/18/2005 | US20050181482 Immunoglobulin/erythropoietin fusion for use in stimulating blood cell production |
| 08/18/2005 | US20050181478 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/18/2005 | US20050181477 Nucleotide sequences coding membrane proteiin receptor for identifying modulators for prevention and treatment of nervous system, vision and cell proliferative disorders; wound healing agents; |
| 08/18/2005 | US20050181476 Novel splice variant of MyD88 and uses thereof |
| 08/18/2005 | US20050181471 artificial polynucleotide for incorporating an unnatural amino acid into a protein and attaching one or more saccharide moieties to the unnatural amino acid; mimetics; expression vector; kits |
| 08/18/2005 | US20050181464 Recombinant enoyl-(acyl-carrier-protein) reductase (NADH) for use as tool in identifying modulators which prevent microbial infection; bactericides |
| 08/18/2005 | US20050181462 Mutant androgen receptor, cancer cells expressing the same, a method of producing them and use thereof |
| 08/18/2005 | US20050181461 Assays for sensory modulators using a sensory cell specific G-protein alpha subunit |
| 08/18/2005 | US20050181458 Bioassay for measuring the proliferation of T-cells in Human papiloma virus |
| 08/18/2005 | US20050181454 Coupling a solid support derived from polystyrene with N-protected derivative of amino acid, removing N-protecting group, coupling the product thus obtained with N-protected derivative of amino acid; removing protecting group, repeating the procedure, coupling, cyclization |
| 08/18/2005 | US20050181450 Novel inositol 1,4,5-trisphosphate (IP3) receptor-binding protein and an IP3 indicator |
| 08/18/2005 | US20050181449 Microarray comprising immobilized cytosolic accessory protein fo identifying modulator for prevention and treatment of heart, lung, bladder and central nervous system disorders |
| 08/18/2005 | US20050181446 Protein variants having modified immunogenicity |
| 08/18/2005 | US20050181445 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/18/2005 | US20050181442 HCaRG, a novel calcium-regulated gene coding for a nuclear protein |
| 08/18/2005 | US20050181439 Streptococcus pneumoniae antigens and vaccines |
| 08/18/2005 | US20050181438 Nucleotide sequences coding monocarboxylate (MCT) transport protein for identifying modulators to treat hyperlysinemia; rational drug design and screening |